Other
Cardiopulmonary rehabilitation
Cardiopulmonary rehabilitation is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
Withdrawn1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
withdrawn125%
unknown125%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
withdrawnnot_applicable
Cardiopulmonary Rehabilitation in Post-acute COVID-19 Syndrome
NCT05539950
completed
Cardio-pulmonary Rehabilitation and Sleep Quality
NCT04668599
unknownnot_applicable
CaRe-ECMO Program on ECMO Weaning
NCT05035797
completednot_applicable
Cardiopulmonary Rehabilitation for Adolescents and Adults With Congenital Heart Disease
NCT01822769
Clinical Trials (4)
Showing 4 of 4 trials
NCT05539950Not Applicable
Cardiopulmonary Rehabilitation in Post-acute COVID-19 Syndrome
NCT04668599
Cardio-pulmonary Rehabilitation and Sleep Quality
NCT05035797Not Applicable
CaRe-ECMO Program on ECMO Weaning
NCT01822769Not Applicable
Cardiopulmonary Rehabilitation for Adolescents and Adults With Congenital Heart Disease
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4